Neurosense Therapeutics Berita Eulerpool

Neurosense Therapeutics Eulerpool News

Neurosense Therapeutics Berita Saham

Neurosense Therapeutics diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Neurosense Therapeutics kami rangkum di sini.

• 9 Juli ·

  Yahoo
  NeuroSense's PARADIGM ALS Clinical Trial Demonstrates Up to 73% Improved Complication-Free Survival Following Statistically Significant Slowing of Disease Progression
• 1 Juli ·

  Yahoo
  NeuroSense Demonstrates Statistically Significant Efficacy and Survival Benefits in People Living with ALS: The Promising Results from the 12-Month PARADIGM Study Highlight PrimeC's Potential as a Disease Modifying Drug
• 27 Juni ·

  TipRanks
  NeuroSense Extends Warrant Termination, Revises Terms
• 24 Juni ·

  Yahoo
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results
• 24 Juni ·

  Thefly.com
  What You Missed On Wall Street This Morning
• 24 Juni ·

  TipRanks
  NeuroSense Advances ALS Treatment, Eyes Phase 3 Trial
• 24 Juni ·

  PR Newswire
  NeuroSense Management Provides Corporate Update and First Quarter 2024 Financial Results
• 24 Juni ·

  Thefly.com
  NeuroSense reports Q1 EPS (35c) vs. (25c) last year
• 24 Juni ·

  Thefly.com
  What You Missed On Wall Street On Monday
• 24 Juni ·

  Seeking Alpha
  NeuroSense Therapeutics GAAP EPS of -$0.35 misses by $0.16